Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A deep-dive into the design choices behind the Krystal 2010 zolpidem extended-release trial, the longest-duration zolpidem efficacy RCT, and what those choices mean for interpreting the results.
Read clinical reviewEconomic analysis of the 6-month Krystal zolpidem extended-release RCT: cost per QALY estimates, payer coverage patterns, list-price versus net-price realities, and patient-level value calculations.
Read clinical reviewDetailed breakdown of the Krystal 2010 zolpidem extended-release RCT results including effect sizes, secondary endpoints, time-course patterns, and response distribution over 6 months.
Read clinical reviewDeep-dive into pre-specified and post-hoc subgroup analyses from the 6-month Krystal zolpidem ER trial, examining differential efficacy by age, sex, BMI, and baseline severity.
Read clinical reviewA deep-dive plain-English breakdown of the Krystal 2010 Sleep trial: methodology, enrollment criteria, endpoints, results tables, limitations, and what the 6-month zolpidem ER data mean for prescribers today.
Read clinical reviewA deep-dive into the clinical-practice implications of the Krystal 2010 zolpidem extended-release RCT: which prescribing patterns should shift, where the trial's population limits generalizability, and what six months of efficacy data actually means at the bedside.
Read clinical review